NutraCea Granted Patent on Proprietary Formula for Joint Health

NutraCea Granted Patent on Proprietary Formula for Joint Health Company receives U.S. Patent Number 6,902,739, from the United States Patent and Trademark Office entitled, Methods for Treating Joint Inflammation, Pain and Loss of Mobility.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning Tharos Laboratories, Inc. Partners with Nature’s Sources, LLC to Expand Sales of NYTEX™ Natural Sleep Supplement Tharos Laboratories, Inc announced that it has signed a distribution agreement with Nature’s Sources, LLC. Through this partnership, Nature’s Sources will build national distribution of Tharos Laboratories’ new product - NYTEX™ Natural Sleep Supplement. Tharos Laboratories, Inc. Partners with Nature’s Sources, LLC to Expand Sales of NYTEX™ Natural Sleep Supplement Tharos Laboratories, Inc announced that it has signed a distribution agreement with Nature’s Sources, LLC. Through this partnership, Nature’s Sources will build national distribution of Tharos Laboratories’ new product - NYTEX™ Natural Sleep Supplement. Tharos Laboratories, Inc. Partners with Nature’s Sources, LLC to Expand Sales of NYTEX™ Natural Sleep Supplement Tharos Laboratories, Inc announced that it has signed a distribution agreement with Nature’s Sources, LLC. Through this partnership, Nature’s Sources will build national distribution of Tharos Laboratories’ new product - NYTEX™ Natural Sleep Supplement. IMG to Promote Fresh Products' New Dual-Purpose Liquid Soap Line Integrated Marketing Group (IMG) has established a working relationship with Fresh Products, Inc., an international cleaning supply manufacturer, distributor and marketer. IMG to Promote Fresh Products' New Dual-Purpose Liquid Soap Line Integrated Marketing Group (IMG) has established a working relationship with Fresh Products, Inc., an international cleaning supply manufacturer, distributor and marketer. IMG to Promote Fresh Products' New Dual-Purpose Liquid Soap Line Integrated Marketing Group (IMG) has established a working relationship with Fresh Products, Inc., an international cleaning supply manufacturer, distributor and marketer. IMG to Promote Fresh Products' New Dual-Purpose Liquid Soap Line Integrated Marketing Group (IMG) has established a working relationship with Fresh Products, Inc., an international cleaning supply manufacturer, distributor and marketer. SunOpta Completes Acquisition of Earthwise Processors Company announces that it has completed the previously announced acquisition of the assets and business of Earthwise Processors, LLC (Earthwise), of Moorhead, Minnesota. SunOpta Completes Acquisition of Earthwise Processors Company announces that it has completed the previously announced acquisition of the assets and business of Earthwise Processors, LLC (Earthwise), of Moorhead, Minnesota. Clemson and Diversa to Collaborate on the Development of Enzymes to Enhance Human Nutrition Clemson University and Diversa Corporation (Nasdaq: DVSA) today announced that they are collaborating to assess opportunities to leverage existing Diversa enzymes that have the potential to enhance human nutrition. The parties will initially focus on evaluating the ability of protein supplements to food to improve stamina and alertness and reduce fatigue. Clemson and Diversa to Collaborate on the Development of Enzymes to Enhance Human Nutrition Clemson University and Diversa Corporation (Nasdaq: DVSA) today announced that they are collaborating to assess opportunities to leverage existing Diversa enzymes that have the potential to enhance human nutrition. The parties will initially focus on evaluating the ability of protein supplements to food to improve stamina and alertness and reduce fatigue. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem® Company has established a close partnership with Kenya-based East African Botanicals (EAB) to significantly increase agricultural cultivation of Artemisia annua and extraction of artemisinin, compound used to produce artemether, one of two active ingredients in Coartem® anti-malarial therapy. VitaCube Systems Holdings, Inc. Appoints New President Company appoints Doug Ridley as its President effective immediately. VitaCube Systems Holdings, Inc. Appoints New President Company appoints Doug Ridley as its President effective immediately. VitaCube Systems Holdings, Inc. Appoints New President Company appoints Doug Ridley as its President effective immediately. VitaCube Systems Holdings, Inc. Appoints New President Company appoints Doug Ridley as its President effective immediately. Naturex, S.A. and Pure World, Inc. Agree to the Acquisition of Pure World, Inc. by Naturex, S.A. for U.S. $4.30 Per Share Companies announce that they have entered into an agreement for Naturex, S.A. to acquire Pure World, Inc. for U.S. $4.30 per share in cash, or approximately U.S. $36.8 million. Naturex, S.A. and Pure World, Inc. Agree to the Acquisition of Pure World, Inc. by Naturex, S.A. for U.S. $4.30 Per Share Companies announce that they have entered into an agreement for Naturex, S.A. to acquire Pure World, Inc. for U.S. $4.30 per share in cash, or approximately U.S. $36.8 million. Naturex, S.A. and Pure World, Inc. Agree to the Acquisition of Pure World, Inc. by Naturex, S.A. for U.S. $4.30 Per Share Companies announce that they have entered into an agreement for Naturex, S.A. to acquire Pure World, Inc. for U.S. $4.30 per share in cash, or approximately U.S. $36.8 million. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. NBTY to Acquire Solgar Company announced it has signed a contract to acquire, for $115 million, substantially all the assets of Solgar Vitamin and Herb, a division of Wyeth Consumer Healthcare. Cargill To Expand OptaFlex(TM) Natural Chondroitin Manufacturing Capabilities in the U.S. Company announces it has completed engineering for a planned expansion of OptaFlex™ natural chondroitin sulfate manufacturing capabilities at its Denver, Colo., facility within the next few months. Cargill To Expand OptaFlex(TM) Natural Chondroitin Manufacturing Capabilities in the U.S. Company announces it has completed engineering for a planned expansion of OptaFlex™ natural chondroitin sulfate manufacturing capabilities at its Denver, Colo., facility within the next few months. Cargill To Expand OptaFlex(TM) Natural Chondroitin Manufacturing Capabilities in the U.S. Company announces it has completed engineering for a planned expansion of OptaFlex™ natural chondroitin sulfate manufacturing capabilities at its Denver, Colo., facility within the next few months. Martek Announces Second Quarter Financial Results Company reports revenues of $55.8 million compared to $41.9 million for the second quarter of fiscal 2004, with income before income taxes of $5.4 million versus $3.4 million prior year. Martek Announces Second Quarter Financial Results Company reports revenues of $55.8 million compared to $41.9 million for the second quarter of fiscal 2004, with income before income taxes of $5.4 million versus $3.4 million prior year. Herbalife Appoints Marcelo Zalcberg as Operations Director of Herbalife Brazil Company announces the appointment of Marcelo Zalcberg as operations director of Herbalife Brazil with responsibility for distributor operations, logistics, regulatory affairs and local manufacturing. Herbalife Appoints Marcelo Zalcberg as Operations Director of Herbalife Brazil Company announces the appointment of Marcelo Zalcberg as operations director of Herbalife Brazil with responsibility for distributor operations, logistics, regulatory affairs and local manufacturing. Herbalife Appoints Marcelo Zalcberg as Operations Director of Herbalife Brazil Company announces the appointment of Marcelo Zalcberg as operations director of Herbalife Brazil with responsibility for distributor operations, logistics, regulatory affairs and local manufacturing. Herbalife Appoints Marcelo Zalcberg as Operations Director of Herbalife Brazil Company announces the appointment of Marcelo Zalcberg as operations director of Herbalife Brazil with responsibility for distributor operations, logistics, regulatory affairs and local manufacturing. NBTY Expands Market Presence in Canada With Acquisition of SISU Inc. Company acquires SISU Inc. for $5.7 million (USD) in cash and will repay SISU's indebtedness of $2.5 million (USD); Canadian vitamin and supplement company had sales of approximately $14 million (USD) for fiscal year ended September 30, 2004. NBTY Expands Market Presence in Canada With Acquisition of SISU Inc. Company acquires SISU Inc. for $5.7 million (USD) in cash and will repay SISU's indebtedness of $2.5 million (USD); Canadian vitamin and supplement company had sales of approximately $14 million (USD) for fiscal year ended September 30, 2004. Zila, Inc. Announces Its Fiscal 2005 Third Quarter Results Company reports revenues of $14.1 million, compared to $12.7 million prior year; nutraceuticals revenues were $10.4 million versus $8.4 million the previoius year. Gross margins for the nutraceuticals group rose to 70% from 65%, due primarily to lower ascorbic acid costs. Zila, Inc. Announces Its Fiscal 2005 Third Quarter Results Company reports revenues of $14.1 million, compared to $12.7 million prior year; nutraceuticals revenues were $10.4 million versus $8.4 million the previoius year. Gross margins for the nutraceuticals group rose to 70% from 65%, due primarily to lower ascorbic acid costs. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. 2004 Sports Nutrition & Weight Loss Sales Up 14% to $15.6 billion Report forecasts that SNWL products will sustain compound annual growth rates of 5-7% the next 8 years, reaching sales of $22.8 billion in 2013. Comprehensive Health Risk Management System for Public Health Centers to be Developed The Regional Health Management Team in the Ministry of Health, Labour and Welfare of Japan published an interim report of discussions since last January on regional health management. The report has specified the policy to develop “a health risk management system led by public health centers” covers diet and health foods, including non-approved pharmaceutical ingredients. Herbalife Appoints Marion Flechtner-Mors, Ph.D., to Medical Advisory Board Company announces the appointment of Marion Flechtner-Mors, Ph.D., to its Medical Advisory Board. Herbalife Appoints Marion Flechtner-Mors, Ph.D., to Medical Advisory Board Company announces the appointment of Marion Flechtner-Mors, Ph.D., to its Medical Advisory Board. Herbalife Appoints Marion Flechtner-Mors, Ph.D., to Medical Advisory Board Company announces the appointment of Marion Flechtner-Mors, Ph.D., to its Medical Advisory Board. Herbalife Appoints Marion Flechtner-Mors, Ph.D., to Medical Advisory Board Company announces the appointment of Marion Flechtner-Mors, Ph.D., to its Medical Advisory Board. GoForLife Labs Announces Change In National Company Identity to Astavita Effective immediately, GoForLife Labs will be known as Astavita. GoForLife Labs Announces Change In National Company Identity to Astavita Effective immediately, GoForLife Labs will be known as Astavita. Frutarom Acquires A.M. Todd's Flavoring Extracts Business Company acquires Flavoring Extracts business of A.M. Todd Botanical Therapeutics; activities 2004 sales were US$ 1.8 million, and represent a potential value of several million dollars of increased revenues over the next few years. Frutarom Acquires A.M. Todd's Flavoring Extracts Business Company acquires Flavoring Extracts business of A.M. Todd Botanical Therapeutics; activities 2004 sales were US$ 1.8 million, and represent a potential value of several million dollars of increased revenues over the next few years. Leiner Health Products Reports Fourth Quarter and Full Year 2005 Results Company reports net sales for the quarter of $174.6 million compared to $168.9 million prior year, notes higher sales of joint care products and lower sales of Vitamin E in light of negative media. Net income was $6.4 million for the quarter, compared to $16.3 million for the same period in fiscal 2004. Leiner Health Products Reports Fourth Quarter and Full Year 2005 Results Company reports net sales for the quarter of $174.6 million compared to $168.9 million prior year, notes higher sales of joint care products and lower sales of Vitamin E in light of negative media. Net income was $6.4 million for the quarter, compared to $16.3 million for the same period in fiscal 2004. Sciona Appoints Roy Whitfield to Board of Directors Company named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board. Sciona Appoints Roy Whitfield to Board of Directors Company named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board. Sciona Appoints Roy Whitfield to Board of Directors Company named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board. Sciona Appoints Roy Whitfield to Board of Directors Company named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board. Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders." Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders." Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders." Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders." Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders." Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	EL DORADO HILLS, Calif., June 8, 2005 /PRNewswire-FirstCall via COMTEX/ -- NutraCea announced today that they have been issued a new patent, U.S. Patent Number 6,902,739, from the United States Patent and Trademark Office entitled, Methods for Treating Joint Inflammation, Pain and Loss of Mobility. The patent contains 14 claims, which include a method for treating lameness, pain and loss of mobility in humans and mammals and a method for inhibiting prostaglandin synthetase activity, which is also known as COX-2 inhibition. According to the Company, the new patent supports NutraCea's strategy of aggressive expansion of its intellectual property portfolio with proprietary technology based solutions that offer unique partnership and licensing opportunities across several multi-billion dollar segments for food, pharmaceutical and specialty healthcare companies. "As Chairman of NutraCea's Medical Advisory Board, we're really pleased to have this patent issued, especially at a time when safe choices for treatment of arthritic pain and inflammation are being challenged with the recall of several pharmaceutical drugs," said Dr. Eliot Drell. "Additionally, this patent is not limited in its application for humans but is extended to include all equine and other mammals as well. We feel it will be a positive step and add additional impetus for our existing product supply relationship with our equine provider; W.F. Young Company is a 113- year-old family-owned company, a leading developer and marketer of health, beauty and grooming products for the equine industry and external analgesics for the human healthcare market sold under the brand name of Absorbine Junior," commented McPeak. About NutraCea(R) NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a waste by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," and all-natural "cosmeceutical" beauty aids. More information can be found in the company's filings with the SEC. and you can visit the NutraCea web site http://www.NutraCea.com. This release contains statements that are forward looking. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software